We are live on ! Find out more
ARKG icon

ARK Genomic Revolution ETF
ARKG

261 hedge funds and large institutions have $535M invested in ARK Genomic Revolution ETF in 2024 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 54 increasing their positions, 93 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

4.42% more ownership

Funds ownership: 37.22% → 41.64% (+4.4%)

8% less funds holding

Funds holding: 284 → 261 (-23)

12% less capital invested

Capital invested by funds: $609M → $535M (-$74.2M)

38% less first-time investments, than exits

New positions opened: 29 | Existing positions closed: 47

41% less call options, than puts

Call options by funds: $98.4M | Put options by funds: $167M

42% less repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 93

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
261
Holders Change
-23
Holders Change %
-8.1%
% of All Funds
3.77%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
29
Increased
54
Reduced
93
Closed
47
Calls
$98.4M
Puts
$167M
Net Calls
-$68.5M
Net Calls Change
+$2.49M

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$28.4M
2
Bank of America
Bank of America
North Carolina
+$15.3M
3
Goldman Sachs
Goldman Sachs
New York
+$14.1M
4
UBS Group
UBS Group
Switzerland
+$12.1M
5
GS
GTS Securities
New York
+$4.28M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$10.5M
2
Citadel Advisors
Citadel Advisors
Florida
-$7.45M
3
LC
Longitude (Cayman)
Cayman Islands
-$2.5M
4
Two Sigma Investments
Two Sigma Investments
New York
-$2.49M
5
Citigroup
Citigroup
New York
-$1.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
KFS
226
Kelly Financial Services
Massachusetts
$1.55K – – –
SVCP
227
Silicon Valley Capital Partners
California
$1.45K – – –
CA
228
CoreCap Advisors
Michigan
$1.24K -$1.29K -51 -49%
RDFA
229
Ritter Daniher Financial Advisory
Ohio
$1.2K – – –
HCM
230
Hollencrest Capital Management
California
$1.17K – – –
HFA
231
Hershey Financial Advisers
Pennsylvania
$1.13K +$1.21K +48 New
PA
232
Parallel Advisors
California
$1.06K -$2.65K -105 -70%
HGERS
233
Householder Group Estate & Retirement Specialist
Arizona
$1K -$4.34K -172 -77%
CMP
234
Coston McIsaac & Partners
Maine
$1K – – –
MWA
235
MFA Wealth Advisors
Pennsylvania
$869 +$934 +37 New
BFO
236
Biltmore Family Office
North Carolina
$822 – – –
KFI
237
Key Financial Inc
Pennsylvania
$822 – – –
WWP
238
WR Wealth Planners
Missouri
$704 – – –
WBC
239
West Branch Capital
Massachusetts
$667 – – –
CAM
240
Chesapeake Asset Management
New York
$590 – – –
BC
241
Barrett & Company
Rhode Island
$587 – – –
MIM
242
Macroview Investment Management
Maryland
$541 – – –
SWM
243
Sanctuary Wealth Management
Idaho
$517 -$1.77K -70 -76%
CP
244
Camelot Portfolios
Ohio
$517 +$555 +22 New
EC
245
EdgeRock Capital
Colorado
$469 +$505 +20 New
JWM
246
Janiczek Wealth Management
Colorado
$404 – – –
EWM
247
Evermay Wealth Management
Virginia
$353 – – –
CFD
248
Creative Financial Designs
Indiana
$307 – – –
Russell Investments Group
249
Russell Investments Group
United Kingdom
$305 +$328 +13 New
YAL
250
Your Advocates Ltd
Texas
$235 – – –
8 9
10
11 12

ARKG Hedge Fund Activity: Q2 2024 in Review

261 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q2 2024, worth a combined $535M — down 12% from $609M a quarter earlier.

Sellers outnumbered buyers: 47 funds closed out of ARKG and 29 opened new positions — a net loss of 18 holders — while 93 trimmed existing stakes and 54 added.

The largest buyer was JP Morgan Chase, adding an estimated $28.4M. The largest seller was Morgan Stanley, cutting an estimated $10.5M.

  • 261 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q2 2024, down from 284 in Q1 2024.
  • Funds reported $535M of ARK Genomic Revolution ETF stock for Q2 2024, down 12% quarter-over-quarter.
  • 29 funds opened new ARK Genomic Revolution ETF positions in Q2 2024 and 47 closed out, a net change of -18 holders.
  • The largest ARK Genomic Revolution ETF buyer in Q2 2024 was JP Morgan Chase, an estimated $28.4M added.
  • The largest ARK Genomic Revolution ETF seller in Q2 2024 was Morgan Stanley, an estimated $10.5M sold.

Based on aggregated 13F filings for Q2 2024.